INOTUZUMAB OZOGAMICIN Pharmacologic Class Indexing

Class set ID
294e7174-3b4a-4eb5-9245-3b4a769e449e
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use BESPONSA™ safely and effectively. See full prescribing information for BESPONSA. BESPONSA (inotuzumab ozogamicin) for injection, for intravenous use Initial U.S. Approval: 2017Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pharmacia & Upjohn Company LLC | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Wyeth Pharmaceutical Division of Wyeth Holdings LLC202602068